RAZ
0
R
PRISM
Explore
Companies
Frontier
Ledger
Method
Workbench
live
←
All collisions
Field dossier · from the corpus
CD19
0
predicted collisions
Where this field is predicted to collide
No open collisions on this field in the current run.
Most cited work
Targeting a CAR to the TRAC locus with CRISPR/Cas9 enhances tumour rejection
2017
1,829 citations
DOI ↗
Long-term outcomes following CAR T cell therapy: what we know so far
2023
1,383 citations
DOI ↗
CAR T Cell Therapy for Solid Tumors
2016
906 citations
DOI ↗
CRISPR/Cas9-mediated PD-1 disruption enhances anti-tumor efficacy of human chimeric antigen receptor T cells
2017
758 citations
DOI ↗